1. Maulik Nanavaty Joins Rani Therapeutics Board

    Maulik Nanavaty Joins Rani Therapeutics Board

    Rani Therapeutics, an InCube Labs company, today announced that Boston Scientific executive Maulik Nanavaty is joining its Board. Nanavaty is currently Senior Vice President and President of Boston Scientific's Neuromodulation Division and a member of its Executive Committee ...

    Read Full Article

    Login to comment.

  1. Categories

    1. BoardProspects Features:

      BoardBlogs, BoardKnowledge, BoardMoves, BoardNews, BoardProspects Announcements, BoardProspects CEO, CEO Blog, In the News, Partner Publications, Question of The Week, Sponsored Content

    1. Rani is entering a critical growth stage, and it is a perfect time to bring Maulik onto our Board.
    2. With Rani's oral biologics platform, Mir and the Rani team have created something very special and potentially ground breaking in the pharma world.
  3. Topics Mentioned